Francesca Buchi

455 total citations
12 papers, 345 citations indexed

About

Francesca Buchi is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Francesca Buchi has authored 12 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 8 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Francesca Buchi's work include Acute Myeloid Leukemia Research (9 papers), Histone Deacetylase Inhibitors Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Francesca Buchi is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Histone Deacetylase Inhibitors Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Francesca Buchi collaborates with scholars based in Italy, United States and Netherlands. Francesca Buchi's co-authors include Valeria Santini, Erico Masala, Antonella Gozzini, Alberto Bosi, Elena Spinelli, Alessandro Sanna, Ana Valencia, Kristen Meldi, Bernardino Allione and Omar Abdel‐Wahab and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Clinical Cancer Research.

In The Last Decade

Francesca Buchi

12 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Buchi Italy 10 263 210 97 29 28 12 345
Catharina Müller‐Thomas Germany 8 218 0.8× 145 0.7× 82 0.8× 29 1.0× 34 1.2× 19 299
Michael Grövdal Sweden 7 243 0.9× 225 1.1× 58 0.6× 15 0.5× 28 1.0× 13 323
R. M. Stone United States 9 189 0.7× 129 0.6× 60 0.6× 21 0.7× 44 1.6× 13 304
Federica Cattina Italy 9 187 0.7× 136 0.6× 80 0.8× 19 0.7× 41 1.5× 35 282
Alun Parsons Finland 10 152 0.6× 174 0.8× 46 0.5× 41 1.4× 53 1.9× 18 304
G. Bug Germany 5 235 0.9× 98 0.5× 87 0.9× 33 1.1× 36 1.3× 7 287
Zach Bohannan United States 7 252 1.0× 141 0.7× 70 0.7× 106 3.7× 19 0.7× 9 349
Ahmad Antar Lebanon 6 269 1.0× 135 0.6× 55 0.6× 50 1.7× 51 1.8× 13 333
Jan Davisson United States 6 333 1.3× 228 1.1× 120 1.2× 22 0.8× 52 1.9× 8 451
Fengkuan Yu China 7 222 0.8× 104 0.5× 67 0.7× 17 0.6× 32 1.1× 25 265

Countries citing papers authored by Francesca Buchi

Since Specialization
Citations

This map shows the geographic impact of Francesca Buchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Buchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Buchi more than expected).

Fields of papers citing papers by Francesca Buchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Buchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Buchi. The network helps show where Francesca Buchi may publish in the future.

Co-authorship network of co-authors of Francesca Buchi

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Buchi. A scholar is included among the top collaborators of Francesca Buchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Buchi. Francesca Buchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Meldi, Kristen, Tingting Qin, Francesca Buchi, et al.. (2015). Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia. Journal of Clinical Investigation. 125(5). 1857–1872. 129 indexed citations
2.
Meldi, Kristen, Omar Abdel‐Wahab, Tingting Qin, et al.. (2014). Molecular Determinants of Decitabine Response in Chronic Myelomonocytic Leukemia. Blood. 124(21). 4644–4644. 1 indexed citations
3.
Alhan, Canan, Theresia M. Westers, Gerwin Huls, et al.. (2014). Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes. Cytometry Part B Clinical Cytometry. n/a–n/a. 12 indexed citations
4.
Alhan, Canan, Theresia M. Westers, Corien Eeltink, et al.. (2014). Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes. Cytometry Part B Clinical Cytometry. 86(3). 207–215. 24 indexed citations
5.
Valencia, Ana, Erico Masala, Alessandro Di Martino, et al.. (2013). Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine. Leukemia. 28(3). 621–628. 70 indexed citations
6.
Buchi, Francesca, Erico Masala, Ana Valencia, et al.. (2013). Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1/ETO target gene IL3. Epigenetics. 9(3). 387–395. 15 indexed citations
7.
Spinelli, Elena, Roberto Caporale, Francesca Buchi, et al.. (2012). Distinct Signal Transduction Abnormalities and Erythropoietin Response in Bone Marrow Hematopoietic Cell Subpopulations of Myelodysplastic Syndrome Patients. Clinical Cancer Research. 18(11). 3079–3089. 25 indexed citations
8.
Buchi, Francesca, Elena Spinelli, Erico Masala, et al.. (2012). Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine. Leukemia Research. 36(5). 607–618. 17 indexed citations
9.
Masala, Erico, Ana Valencia, Francesca Buchi, et al.. (2012). Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells. Leukemia Research. 36(10). 1290–1295. 13 indexed citations
10.
Buchi, Francesca, Roberta Pastorelli, Germano Ferrari, et al.. (2011). Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid. Leukemia Research. 35(7). 921–931. 12 indexed citations
11.
Santini, Valeria, Elena Spinelli, Roberto Caporale, et al.. (2009). C003 Proliferative and apoptotic signalling in bone marrow cell subpopulations of myelodysplastic syndromes patients using flow-cytometry technique. Leukemia Research. 33. S32–S32. 1 indexed citations
12.
Ferrari, Germano, Roberta Pastorelli, Francesca Buchi, et al.. (2006). Comparative Proteomic Analysis of Chronic Myelogenous Leukemia Cells:  Inside the Mechanism of Imatinib Resistance. Journal of Proteome Research. 6(1). 367–375. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026